Filtered By:
Specialty: Infectious Diseases
Vaccination: Vaccines

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2378 results found since Jan 2013.

Neonatal erythema multiforme associated with a rotavirus infection: A case report
CONCLUSION: The possibility of rotavirus, a major cause of pediatric gastrointestinal infections, being a trigger for neonatal EM should be considered.PMID:37727716 | PMC:PMC10506005 | DOI:10.12998/wjcc.v11.i24.5749
Source: Herpes - September 20, 2023 Category: Infectious Diseases Authors: Jung Jae Kim Joon Kee Lee Source Type: research

Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: A national cohort study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes mortality [1]. These deaths may occur because of factors related to the virus, the host, and available vaccinations and treatments. For example, death from coronavirus disease 2019 (COVID-19) may occur because of the infection's capacity to cause harm that results in death in otherwise healthy persons (viral virulence deaths). COVID-19-associated death may also occur because SARS-CoV-2 infection exacerbates the health condition of people who are more vulnerable to death in the short-term independent of the virus because of severe underlying coexi...
Source: International Journal of Infectious Diseases - September 15, 2023 Category: Infectious Diseases Authors: Hiam Chemaitelly, Jeremy Samuel Faust, Harlan M. Krumholz, Houssein H. Ayoub, Patrick Tang, Peter Coyle, Hadi M. Yassine, Asmaa A. Al Thani, Hebah A. Al-Khatib, Mohammad R. Hasan, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeck Source Type: research

Clusters of SARS-CoV-2 Infection Across Six Schools for Students with Intellectual and Developmental Disabilities
ConclusionThe Omicron variant led to an increase in cluster-based transmission, and staying up to date with vaccination guidelines was crucial in limiting transmission.Clinical Trial RegistrationPrior to enrollment, this study was registered at ClinicalTrials.gov on September 25, 2020 (identifier NCT04565509; titled “Supporting the Health and Well-being of Children with Intellectual and Developmental Disability During COVID-19 Pandemic”).
Source: Infectious Diseases and Therapy - September 13, 2023 Category: Infectious Diseases Source Type: research

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
ConclusionsBNT162b2 coadministered with SIIV elicited immune responses that were noninferior to those elicited by BNT162b2 alone and SIIV alone, and BNT162b2 had an acceptable safety profile when coadministered with SIIV. The results of this study support the coadministration of BNT162b2 and SIIV in adults.Trial RegistrationClinicalTrials.gov registration: NCT05310084.
Source: Infectious Diseases and Therapy - September 12, 2023 Category: Infectious Diseases Source Type: research

Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.ABSTRACTDespite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-...
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Nouf F Bin Rubaian Abdullah A Aljalfan Serene R Almuhaidib Source Type: research

Spike Protein is a key target for stronger and more persistent T-Cell Responses – A study of mild and asymptomatic SARS-CoV-2 Infection.
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus led to devastating consequences, with over 768,983,095 confirmed cases and 6,953,743 million deaths reported as of 26th July 2023 (WHO, 2023 https://covid19.who.int/). Highlighting the critical importance of both T-cell and antibody responses is imperative for effectively addressing the complexities posed by COVID-19. Amidst the significant antibody research, there's a growing realisation that understanding and leveraging T-cell responses is pivotal for designing efficacious SARS-CoV-2 vaccines ...
Source: International Journal of Infectious Diseases - September 6, 2023 Category: Infectious Diseases Authors: Ivan Ssali, Susan Mugaba, Arthur Kalyebi Watelo, Juliana Bemanzi, Joseph Ssebwana Katende, Gerald Kevin Oluka, Violet Ankunda, Claire Baine, Laban Kato, The COVID-19 Immunoprofiling Team, Nathan Onyachi, Moses Muwanga, Mark Jjuuko, John Kayiwa, Christophe Source Type: research

Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study
CONCLUSIONS: A sizeable proportion of older adults who received other recommended vaccines during the last influenza season did not receive SIV. This share of missed opportunities, which are subject to some social inequalities, may be addressed by increasing vaccine co-administration rates and implementing tailored health promotion interventions.PMID:37632235 | DOI:10.1093/eurpub/ckad155
Source: Herpes - August 26, 2023 Category: Infectious Diseases Authors: Alexander Domnich Andrea Orsi Matilde Ogliastro Carlo-Simone Trombetta Marianna Scarpaleggia Chiara Ceccaroli Carla Amadio Anna Raffo Luca Berisso Alla Yakubovich Giacomo Zappa Daniela Amicizia Donatella Panatto Giancarlo Icardi Source Type: research

Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical update
Infect Disord Drug Targets. 2023 Aug 16. doi: 10.2174/1871526523666230816151614. Online ahead of print.ABSTRACTPositive strides have been achieved in developing vaccines to combat the coronavirus-2019 infection (COVID-19) pandemic. Still, the outline of variations, particularly the most current delta divergent, has posed significant health encounters for people. Therefore, developing strong treatment strategies, such as an anti-COVID-19 medicine plan, may help deal with the pandemic more effectively. During the COVID-19 pandemic, some drug design techniques were effectively used to develop and substantiate relevant critica...
Source: Infectious Disorders Drug Targets - August 16, 2023 Category: Infectious Diseases Authors: Abu Mohiuddin Sumanta Mondal Source Type: research